Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Molecular Pathogenesis of Plasma Cell Disorder

Clinical Trial Details

The goal of this study is to better understand the biology underlying plasma cell disorders.

To accomplish this goal, we have created a database-biorepository which is being used by investigators at Weill Cornell Medicine and their collaborators. By studying the clinical course of patients with plasma cell disorders, and by performing basic laboratory studies using their tissue, we hope to improve patient care.

Key Eligibility: 
  1. All patients with plasma cell disorders who are at least 18 years of age.
  2. Patients who consent to participate in this research study may also be asked to contact family members to determine their willingness to participate in this study. No family member will be contacted without the consent of the patient and that family member. To ensure confidentiality, no medical information provided by one family member is discussed with any other.

Detailed eligibility will be discussed with the study team.

Study contact by location

Upper East Side - Manhattan


Kathleen Pogonowski, RN
(646) 962-6500



Kelsey Maguire Torres, RN

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:



Open to Enrollment

Age Group